Diabetes TechnologyNCT07822945
Healthcare Practitioners Knowledge on Diabetes Technology
An observational study of Diabetes Technology and Continuous Glucose Monitoring System, run by Aristotle University Of Thessaloniki at 1 site in Greece.
Trial summary
Assessment of knowledge of healthcare professionals of diabetes mellitus technology (continuous glucose monitoring systems and insulin pump therapy). The study is a cross-sectional, quantitative study at a tertiary university hospital in Thessaloniki, Greece Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Diabetes Technology, Continuous Glucose Monitoring System, Continuous Insulin Infusion System
- What is being tested?
- Questionnaire assessing knowledge on diabetes technology
- How many people
- 112 participants
- Where
- 1 siteGreece
- Study dates
- 1 Jun 2025to 30 Sep 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Healthcare professionals practicing at the University General Hospital of Thessaloniki "AHEPA"
Who may be able to join
- All qualified and registered HCP practicing at the University General Hospital of Thessaloniki "AHEPA" , who were involved in direct patient care.
- Actively working during the data collection period.
Who cannot join
- Administrative staff and personnel not directly involved in patient care.
- HCP who declined to participate.
- Participants who did not complete the questionnaire in full.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Zisis Kontoninas, MD, PhD contact
Greece1 site, 1 recruiting
- Recruiting
University General of Thessaloniki AHEPA
Thessaloniki, 54636
Triantafyllos Didangelos, Professor of Internal Medicine, +302310994776, didang@auth.gr
Zisis Kontoninas, MD, PhD, drziko2401@gmail.com
About this study
Official title: Healthcare Professionals' Knowledge of Continuous Glucose Monitoring and Insulin Pump Therapy
Assessment of knowledge of healthcare professionals of diabetes mellitus technology (continuous glucose monitoring systems and insulin pump therapy). The study is a cross-sectional, quantitative study at a tertiary university hospital in Thessaloniki, Greece
Read the detailed description
Data will be collected using a standardized questionnaire. This questionnaire is based on a review of the relevant literature on diabetes management and related technologies. The final instrument consists of 37 closed-ended items. It was organized into four main sections, covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. Demographics will be also collected along with diabetes knowledge questions and 2 sections (1 for insulin pumps and 1 for continuous glucose monitoring).
- Conditions
- Diabetes Technology, Continuous Glucose Monitoring System, Continuous Insulin Infusion System, Insulin Pump Therapy
- Being tested
- Questionnaire assessing knowledge on diabetes technology
- Keywords
- healthcare professional, diabetes technology, continuous glucose monitoring, insulin pump therapy, continuous insulin infusion system
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Questionnaire assessing knowledge on diabetes technologyOther
A standardized questionnaire developed specifically based on a review of the relevant literature on diabetes management and related technologies
| Study group | Role | What they receive |
|---|---|---|
| Observation group | Healthcare professionals working in a tertiary university hospital Receives: Other: Questionnaire assessing knowledge on diabetes technology |
What is being measured
The primary outcome is the main question the study is designed to answer.
Knowledge of Diabetes Mellitus aspects
Questions on diabetes types, diagnostic criteria, risk factors for hypo- and hyperglycemia, symptom recognition, and glycemic targets.
Measured: Through study completion, an average of 1 year and 3 months
Secondary outcomes (2)
knowledge on insulin use
The instrument was a questionnaire of 37 closed ended items organized in 4 sections covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. The questions for insulin use covered the knowledge of healthcare professionals on insulin regimens, dose calculation and administration, principles and benefits of insulin pump therapy, potential complications and appropriate actions in case of device malfunction.
Measured: Through study completion, an average of 1 year and 3 months
Knowledge of healthcare professionals on continuous glucose monitoring systems
Questions on system function, accuracy, indications for use, contribution to glycemic control, sensor placement and common issues during use.
Measured: Through study completion, an average of 1 year and 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2026
- Study start1 Jun 2025
- Primary completion15 Sep 2026 (estimated)
- Study completion30 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetes TechnologyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 112 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Aristotle University Of Thessaloniki
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Prof. Triantafyllos Didangelos, Aristotle University Of Thessaloniki
- Investigators
- Triantafyllos Didangelos, Principal investigator, Aristotle University Of ThessalonikiZisis Kontoninas, MD, PhD, Study director, Aristotle University Of Thessaloniki
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07822945
- Sponsor's protocol ID
- 219/2025
- Status last verified
- Sep 2026
- First submitted
- 4 Sep 2026
- Last updated
- 16 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared because of the General Data Protection Regulation and the regulations of the Ethics committee of the hospital
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Healthcare Professionals' Knowledge of Continuous Glucose Monitoring and Insulin Pump Therapy
- ClinicalTrials.gov ID
- NCT07822945
- Acronym / sponsor ID
- 219/2025
- Conditions
- Diabetes Technology, Continuous Glucose Monitoring System, Continuous Insulin Infusion System, Insulin Pump Therapy
- Keywords
- healthcare professional, diabetes technology, continuous glucose monitoring, insulin pump therapy, continuous insulin infusion system
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 112 participants (estimated)
- Lead sponsor
- Aristotle University Of ThessalonikiUniversity, hospital or other
- Study start
- 1 Jun 2025 (actual)
- Primary completion
- 15 Sep 2026 (estimated)
- Study completion
- 30 Sep 2026 (estimated)
- First posted
- 16 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Assessment of knowledge of healthcare professionals of diabetes mellitus technology (continuous glucose monitoring systems and insulin pump therapy). The study is a cross-sectional, quantitative study at a tertiary university hospital in Thessaloniki, Greece
Detailed description
Data will be collected using a standardized questionnaire. This questionnaire is based on a review of the relevant literature on diabetes management and related technologies. The final instrument consists of 37 closed-ended items. It was organized into four main sections, covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. Demographics will be also collected along with diabetes knowledge questions and 2 sections (1 for insulin pumps and 1 for continuous glucose monitoring).
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Observation group | – | Other: Questionnaire assessing knowledge on diabetes technologyHealthcare professionals working in a tertiary university hospital |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Healthcare professionals practicing at the University General Hospital of Thessaloniki "AHEPA"
Key inclusion criteria (2 listed)
- All qualified and registered HCP practicing at the University General Hospital of Thessaloniki "AHEPA" , who were involved in direct patient care.
- Actively working during the data collection period.
Key exclusion criteria (3 listed)
- Administrative staff and personnel not directly involved in patient care.
- HCP who declined to participate.
- Participants who did not complete the questionnaire in full.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Questionnaire assessing knowledge on diabetes technologyA standardized questionnaire developed specifically based on a review of the relevant literature on diabetes management and related technologies | Other | Observation group |
Primary outcome
Knowledge of Diabetes Mellitus aspects
Time frame: Through study completion, an average of 1 year and 3 months
Questions on diabetes types, diagnostic criteria, risk factors for hypo- and hyperglycemia, symptom recognition, and glycemic targets.
2 secondary outcomes
knowledge on insulin use
Time frame: Through study completion, an average of 1 year and 3 months
Knowledge of healthcare professionals on continuous glucose monitoring systems
Time frame: Through study completion, an average of 1 year and 3 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared because of the General Data Protection Regulation and the regulations of the Ethics committee of the hospital
Related trials for Diabetes Technology
Recruiting
Feasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1 Diabetes
Diabetes Mellitus, Type 1 Diabetes, Mobile Health Platform
Not yet recruiting
Zirconia-Reinforced Glass Ionomer Versus Injectable Giomer in Class V Restorations
Class V Dental Caries, Type 2 Diabetes Mellitus, Giomer Technology; Injectable Resin Composite; Zirconia-Modified Glass Ionomer
Recruiting
Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology
Sonic Augmentation Technology
Not yet recruiting
Testing a Smart Medication Dispenser (Mobili®) to Help People With Chronic Conditions Take Their Medicine
Dose Administration Aids, Medication Adherence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Zisis Kontoninas, MD, PhD contact
Triantafyllos Didangelos principal investigator
Aristotle University Of Thessaloniki
Zisis Kontoninas, MD, PhD study director
Aristotle University Of Thessaloniki
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Diabetes Technology and Continuous Glucose Monitoring System, run by Aristotle University Of Thessaloniki at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Triantafyllos Didangelos, Professor of Internal Medicine (+302310994776, didang@auth.gr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knowledge of Diabetes Mellitus aspects (time frame: Through study completion, an average of 1 year and 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026; AzTrials last refreshed its copy on 30 Oct 2026.